Biosimilar Adoption at National CooperativeRx
Erica Guetzlaff
March 5, 2026
Biosimilars have become an increasingly important part of modern healthcare. As “highly similar” alternatives to brand name biologic drugs…
National CooperativeRx
Blog
National CooperativeRx Pipeline Report 2026
Jacki Fritsche
February 10, 2026
National CooperativeRx constantly monitors the pharmaceutical pipeline for new drugs that will be entering the market…
Three Ways Staying Engaged Helps Optimize Pharmacy Benefit Plans
Deb Thomsen
February 6, 2026
Pharmacy benefit plans are not something you can set and forget. With the pace of change in the pharmacy benefit landscape, new challenges and opportunities can emerge at any time. That’s why ongoing engagement…
2026 Outlook: Plenty of Industry Changes
Josh Bindl
January 6, 2026
National CooperativeRx is steadfast in navigating pharmacy complexities with the best interest of patients and our membership at the center of every decision. The pharmacy benefit landscape remains very active…
2025 in Review and What’s Next for Pharmacy Benefits in 2026
Wayne Salverda
December 16, 2025
Yet another year ends. Check out our 2025 recap and insights on what might be in store for 2026…
Christine Newsom: Strategic Account Executive
National CooperativeRx
December 15, 2025
National CooperativeRx is pleased to introduce Christine Newsom, Strategic Account Executive, to our members and partners. As a strategic account executive, Christine…
Sign Up for Our Newsletter
